Company / PP&E (Net)
Beta Bionics, Inc. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$8.6M
FY2025
5-year range
$2.5M / $8.6M
FY2023-FY2025
Trend
+80.1%
vs FY2024
Sector context
#121 of 132
Health Care
What the data says
Among 132 Health Care companies, Beta Bionics, Inc. is in the bottom 8% for pp&e (net). Improved from $2M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025.
Improved from $2M to $9M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 132This company $8.6M Sector average $1.4B
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, pp&e (net) increased 80.1% year-over-year.
- Ranks #121 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.6M | +80.1% |
| FY2024 | $4.8M | +92.9% |
| FY2023 | $2.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026